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Background: Cardiac function is associated with cognitive function. Previously, we
found that stroke and traumatic brain injury evoke cardiac dysfunction in mice. In this
study, we investigate whether bilateral common carotid artery stenosis (BCAS), a model
that induces vascular dementia (VaD) in mice, induces cardiac dysfunction.
Methods: Late-adult (6–8 months) C57BL/6J mice were subjected to sham surgery
(n = 6) or BCAS (n = 8). BCAS was performed by applying microcoils (0.16 mm
internal diameter) around both common carotid arteries. Cerebral blood flow and
cognitive function tests were performed 21–28 days post-BCAS. Echocardiography was
conducted in conscious mice 29 days after BCAS. Mice were sacrificed 30 days after
BCAS. Heart tissues were isolated for immunohistochemical evaluation and real-time
PCR assay.
Results: Compared to sham mice, BCAS in mice significantly induced cerebral
hypoperfusion and cognitive dysfunction, increased cardiac hypertrophy, as indicated
by the increased heart weight and the ratio of heart weight/body weight, and induced
cardiac dysfunction and left ventricular (LV) enlargement, indicated by a decreased LV
ejection fraction (LVEF) and LV fractional shortening (LVFS), increased LV dimension
(LVD), and increased LV mass. Cognitive deficits significantly correlated with cardiac
deficits. BCAS mice also exhibited significantly increased cardiac fibrosis, increased
oxidative stress, as indicated by 4-hydroxynonenal and NADPH oxidase-2, increased
leukocyte and macrophage infiltration into the heart, and increased cardiac interleukin-6
and thrombin gene expression.
Conclusions: BCAS in mice without primary cardiac disease provokes cardiac
dysfunction, which, in part, may be mediated by increased inflammation and
oxidative stress.
Keywords: bilateral common carotid artery stenosis, brain–heart interaction, cardiac dysfunction, inflammation,
oxidative stress
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INTRODUCTION

between employing 0.16- and 0.18-mm diameter coils. In a
previous study, mortality with 0.16-mm microcoils was 75% and
that with 0.18-mm microcoils was 15% at 14 days after BCAS
(10). CBF recovered to ∼70% of the baseline value in mice
with 0.16-mm microcoils and remained significantly reduced
compared to the control mice, whereas it recovered to ∼80% and
no significant difference was detected compared to the control
group with the 0.18-mm microcoils 30 days after BCAS (12, 17).
In the 0.18-mm microcoil model, there were no infarctions or
hemorrhage in gray matter regions at 30 days. Animals with 0.16mm microcoils exhibited focal infarction histological changes
(10). Thus, using 0.16-mm microcoils induces more severe brain
damage and chronic cerebral hypoperfusion. To reduce the
early mortality, we employed an interval of 60 min between
applications of microcoils.

Vascular dementia (VaD) is one of the most common causes of
dementia, responsible for ∼15% of the cases after Alzheimer’s
disease (1). VaD has emerged as a predominant health problem
worldwide in the elderly, with great impact on families and
national economies, and there is no effective treatment (2). VaD
is induced by a decrease in cerebral blood flow (CBF), which
triggers inflammatory responses and oxidative stress, provoking
lesions in the hippocampus, white matter, and basal ganglia (3).
From a patient cohort study, a low cognitive score is associated
with an increased incidence of cardiac vascular events (4). In
addition, the presence of cardiovascular disease is associated with
an increased risk of late-life cognitive impairment and dementia
(5, 6).
Although there are extensive investigations on how cardiac
dysfunction drives cognitive deficits (7), what has not been
investigated is the converse, whether primary cerebrovascular
events that result in cerebral hypoperfusion affect cardiovascular
function. Our previous studies have found that brain damage,
such as stroke and traumatic brain injury (TBI), induces cardiac
deficit in mice even in the absence of primary cardiac diseases (8,
9). Here, we investigate whether bilateral common carotid artery
stenosis (BCAS), which induces VaD in late-adult mice, induces
cardiac deficits in non-primary cardiac disease mice. BCASinduced pathologies parallel the underlying pathophysiological
alterations evoking dementia found in patients with VaD (10–
16). Therefore, the BCAS model was employed in this study. We
propose that primary cerebral hypoperfusion which drives VaD
provokes cardiac deficits.

Cerebral Blood Flow Test
Regional CBF (rCBF) was measured in anesthetized mice 14
days after BCAS using laser Doppler flowmetry (LDF; PeriFlux
PF4, Perimed AB, Datavagen, Sweden), as described previously
(18, 19). Using a midline scalp incision, the skull was exposed
and non-contact cortical rCBF was continuously recorded as
perfusion units. The probe was placed in a fixed position of
bregma and midline intersection while maintaining consistent
acquisition parameters and region of interest for all mice at all
time points of measurement.

Cognitive Function Tests
Three cognitive function tests, including the Morris water maze
(MWM) test (20), three-chamber sociability test (21), and the
odor test (22), were performed following previously described
methods 21–28 days after BCAS by an investigator blinded to the
experimental groups. The modified neurological severity score
(mNSS) was used for evaluating sensorimotor function.

MATERIALS AND METHODS
All experiments were conducted in accordance with the
standards and procedures of the American Council on Animal
Care and with the approval of the Institutional Animal Care and
Use Committee of Henry Ford Health System. This manuscript
was prepared in accordance with ARRIVE guidelines.

Morris Water Maze
The MWM test, which spans 5 days and consists of four 90s trials per day, is used to evaluate spatial and visual learning
and memory. It relies on the navigation of mice in an open
swimming pool to locate a submerged escape platform. The
following parameters were recorded for each trial: escape latency,
i.e., the time taken by the mice to reach the hidden platform,
swim speed, and total swim distance. Data were collected using
the ANY-Maze software, and the average over four trials for each
day was calculated.

BCAS Model and Experimental Procedure
Male (6–8 months old) C57BL/6J wild-type (WT) mice (weight
= 28–32 g, n = 8) were subjected to BCAS, as previously
described (10). Mice were anesthetized with 4% isoflurane in a
chamber for pre-anesthesia and spontaneously respired with 2%
isoflurane in a 2:1 N2 O/O2 mixture using a facemask connected
and regulated with a modified Fluotec 3 vaporizer (Fraser
Harlake, Orchard Park, NY, USA). Both common carotid arteries
(CCA) were exposed by a middle cervical incision. A microcoil
(internal = 0.16 mm, spring: 5, material SUS304; RuikeBiotech
Company, Xi’an, China) was applied by rotating it around the
right CCA; after an interval of 1 h, a second microcoil was
applied around the left CCA. The coils were permanently left
in place. The early mortality in the BCAS group is 25% (two
of eight mice). Sham mice (n = 6) were subjected to the same
surgical procedures without the application of microcoils. Mice
were sacrificed 30 days after BCAS for immunohistochemical
staining and real-time PCR analysis. Several differences exist
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Three-Chamber Sociability Test
This test evaluates sociability and preference for social novelty.
The testing apparatus consists of three interconnected chambers
and the testing regimen comprises three phases: a habituation
phase, a sociability task, and a preference for social novelty
test. For the sociability task, the test mouse is given the option
to interact with a stranger (S1) mouse housed within a small
wire cage or an empty wire cage placed in the right and left
compartments of the apparatus. For the social novelty task, the
test mouse has the option to interact with the stranger 1 (S1) or a
stranger 2 (S2) mouse, housed in wired cages in the right and left
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The odor test evaluates olfactory learning and memory based
on the animal’s preference for new smells. The test spans 3
days, during which the animals are individually housed. The
first day comprises habituation, during which four wooden beads
(http://www.craftworks.com) were placed in the cages to serve
as familiar odor (F). Day 2 comprises three trials, each spanning
1 min, during which the animals are familiarized to a donor smell
(N1). Mice are freely allowed to explore three familiar beads
(F) and one novel odor bead (N1) placed in the center of the
cage. The position of N1 bead was randomly varied for each
trial to minimize spatial cues, and an inter-trial interval of 1 mi
void of any beads was used to minimize olfactory adaptation.
Following a 24-h retention delay, mice are subject to a test phase
spanning 1 min, during which the mice freely explore four beads
(N1, N2, and two F beads) placed in the center of the cage.
The time spent exploring (sniffing, licking, or biting) each bead
was recorded during the test phase and a discrimination index
calculated as the ratio between the time spent exploring N2 to the
total exploration time.

containing four fields of view, were imaged. Picrosirius Red (PSR,
staining collagen I/III and muscle fibers as a fibrosis marker,
1:1,000; Sigma, St. Louis, MO, USA) staining was employed to
measure perivascular fibrosis and interstitial collagen fraction
(ICF). To study the immune response and oxidative stress
after BCAS in the heart, antibody against CD45 (a marker
for leukocyte, 1:250; Abcam, Cambridge, MA, USA), IBA1 (a
marker for monocytes/macrophages, 1:1,000; Wako, Mountain
View, CA, USA,), CD86 (M1 macrophage marker, 1:100; Abcam,
Cambridge, MA, USA), 4-hydroxynonenal (4HNE, 1:1,000;
Millipore Sigma, St. Louis, MO), and NOX-2 (NADPH oxidase
2, 1:400; BD, Franklin Lakes, NJ, USA) were employed. DAPI
counterstain was used to stain nuclei in immunofluorescent
staining. Negative controls consisted of similar procedures, but
without the addition of the primary antibody.
For immunostaining measurements, positive cell numbers
were counted for each field of view or the positive areas
were measured using the densitometry function (MCID image
analysis system) with a density threshold above the unstained set
uniformly for all groups. Data from five sections, and four regions
within each section, were averaged to obtain a single value for
each animal and presented as the number of positive cells per
square millimeter or the percentage of positive area.

Modified Neurological Severity Score

Polymerase Chain Reaction

compartments of the apparatus. The times spent interacting with
S1 vs. empty and S1 vs. S2 are recorded for the task.

Odor Test

The mNSS includes a composite of motor, sensory, reflex, and
balance tests, as previously described (23). On a scale of 0–18, 0
indicates the absence of neurological deficits, while higher scores
indicate severe neurological injury and function.

To test the expressions of inflammatory cytokines, total heart
RNA was isolated and utilized to perform quantitative PCR
following standard protocol (27). The samples were tested by an
investigator blinded to the experimental groups. Relative gene
expression was analyzed using the 2−11Ct method.

Echocardiography

GAPDH: Forward: GCCAAGGCTGTGGGCAAGGT
Reverse: TCTCCAGGCGGCACGTCAGA
Interleukin-6 (IL-6): Forward: TGATGCACTTGCAGAAAACA
Reverse: ACCAGAGGAAATTTTCAATAGGC
Thrombin: Forward: AGGACAATCTGTCACCTCCACT
Reverse: GGTCGAAGTCTTGGTACTTGCT.

Cardiac function was evaluated in conscious mice 29 days after
BCAS. Transthoracic echocardiography measurements were
obtained using an Acuson C516 (Siemens) machine equipped
with a 15-MHz linear transducer (15L-8) (24, 25). Mice
were trained for 3 days before performing echocardiography
measurements to minimize bradycardia and the left hemithorax
was shaved prior to testing. Each mouse was picked up
by the nape of the neck, held firmly in the palm of one
hand in the supine position, and a pre-warmed ultrasound
transmission gel applied to the chest. M-mode images of the
left ventricle (LV) from long-axis as well as short-axis views
were recorded. All measurements were digitized by goal-directed,
diagnostically driven software and three beats were averaged
for each measurement. The left ventricular ejection fraction
(LVEF) was measured using the formula: LVEF = [(LVAd –
LVAs)/LVAs × 100], where LVAd is the LV diastolic area and
LVAs is the LV systolic area. Relative wall thickness (RWT)
was calculated as 2 × posterior wall thickness/LV end-diastolic
diameter (26). All data were analyzed off-line at the end of
the study with software resident on the ultrasound system, and
all measurements were performed by an investigator who was
blinded to the experimental groups.

Statistical Analysis
Two-way analysis of variance (ANOVA) was utilized for the
MWM outcome. Unpaired two-tailed Student’s t-test was used
to test significance of the two groups with GraphPad Prism
8 (Graph Pad Software Inc., San Diego, CA, USA). The
relationship between the cognitive functional outcome and LVEF
was analyzed using Pearson’s correlation coefficients. ∗ P < 0.05
was considered statistically significant. Data in all figures are
presented as the mean ± SEM.

RESULTS
BCAS Induces Chronic Hypoperfusion and
Cognitive Deficit
To test whether BCAS induces chronic cerebral hypoperfusion,
CBF was measured at day 14 after BCAS (Figure 1). Figure 1A
shows a significantly decreased CBF after BCAS compared to
the sham group. To investigate whether BCAS induces cognitive
deficit, three function tests were employed. We found that BCAS

Immunostaining
Heart coronal sections (6 µm thick) were cut from paraffinembedded blocks. Five sections from each heart, with each slide
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FIGURE 1 | Bilateral common carotid artery stenosis (BCAS) significantly induces hypoperfusion and cognitive dysfunction compared to sham mice. (A) Cerebral
blood flow (CBF) measurement 14 days after BCAS. (B) Latency of the Morris water maze (MWM). (C) Odor test. (D) Social test. n = 6/group. *p < 0.05.

show that BCAS mice exhibit significantly increased LV mass,
reduced LVEF and left ventricular fractional shortening (LVFS),
and increased left ventricular dimension (LVD) without any
change in the heart rate compared to sham control mice as
measured by echocardiography. BCAS mice exhibited a declining
trend in RWT (p = 0.09). Our data indicate that BCAS results in
cardiac systolic dysfunction and eccentric hypertrophy in mice
even in the absence of primary cardiac disease.

mice exhibit a significantly increased escape latency on all 5
days of the MWM test compared to sham (Figure 1B). BCAS
significantly decreases the discrimination index in the odor test
and the social test, indicating significant memory impairment
compared to sham mice, as shown in Figures 1C,D. Our
data indicate that BCAS significantly induces chronic cerebral
hypoperfusion and leads to cognitive impairment. On a scale of
0–18, where 0 indicates a lack of neurological deficits and 18
indicates maximum and severe neurological deficits, an mNSS
score <6 is generally considered to indicate mild neurological
deficits with small to no ischemic infarct. Compared to the sham
control group, VaD mice exhibited mild neurological deficits on
day 21 after BCAS (control = 0 ± 0; BCAS = 4.6 ± 1.03). Also,
the mean swim speed of BCAS mice was significantly reduced
on days 1 and 4 of the MWM test compared to sham mice
(Supplementary Figure 1A). Therefore, we cannot rule out that
motor deficits may contribute to some of the differences observed
in the MWM test.

Cognitive Dysfunction Significantly
Correlates to Cardiac Dysfunction
Pearson’s correlation test (Figure 3) was used to evaluate
the correlations between cognitive dysfunction and cardiac
dysfunction, and we found that the sociability test S2%
discrimination index, odor test discrimination, CBF, and MWM
latency were significantly correlated with LVEF, as shown in
Figures 3A–D. LVEF is a primary index of cardiac function
(30). Our data indicate that cardiac dysfunction is related to
cognitive dysfunction.

BCAS Induces Cardiac Hypertrophy and
Dysfunction Compared to Sham Mice

BCAS Induces Cardiac Fibrosis and
Oxidative Stress Compared to Sham Mice

To test whether BCAS affects cardiac function, heart weight and
echocardiography measurements were performed in conscious
mice (Figure 2). The heart rate and systolic function in conscious
mice are typically much higher than those seen in anesthetized
mice (28, 29). Figure 2A shows that BCAS significantly increases
the heart weight and the ratio of heart weight/body weight
(HW/BW). Figures 2B–E and Supplementary Figures 1B,C
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PSR staining was performed (Figure 4) to investigate whether
BCAS induces cardiac fibrosis. BCAS mice exhibited significantly
increased interstitial and perivascular fibrosis compared to sham
mice, as shown in Figures 4A,B. Our data indicate that BCAS
induces cardiac fibrosis. Immunostaining was employed to assess
oxidative stress in the heart. Figures 4C,D indicate that BCAS
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FIGURE 2 | Bilateral common carotid artery stenosis (BCAS) induces cardiac hypertrophy and cardiac dysfunction compared to sham mice. (A) Heart weight (HW)
and ratio of HW to body weight (BW). (B) Left ventricular (LV) mass. (C) Echocardiography figures of sham and BCAS mice. (D) Left ventricular ejection fraction (LVEF)
and left ventricular fractional shortening (LVFS) measurements. (E) Left ventricular diameter (LVD) at diastole and systole. n = 6/group. *p < 0.05.

significantly increases 4HNE and NOX-2 in the BCAS group
compared to the sham group. Our data indicate that BCAS
increases oxidative stress in heart.

thrombin significantly increased in the heart of mice subjected to
BCAS compared to sham mice, respectively. Our data indicate
that BCAS induces increased inflammatory factor expression in
the heart.

BCAS Significantly Increases Cardiac
Inflammatory Response

DISCUSSION

To determine whether BCAS induces inflammatory cell
infiltration, we employed immunostaining (Figure 5). Figure 5A
shows that BCAS significantly increased leukocyte infiltration
compared to sham mice. Macrophage infiltration increased in
BCAS mice compared to sham mice, as shown in Figure 5B.
To determine the macrophage phenotype, we employed CD86
immunostaining and found that M1 macrophage increased in
the BCAS group compared to the sham group (Figure 5C).
To investigate possible mechanisms by which BCAS induces
cardiac dysfunction, real-time PCR was employed. Figures 5D,E
show that the expressions of the inflammatory cytokines IL-6 and

In this study, we used a BCAS model to induce VaD.
We found that BCAS not only significantly induces chronic
hypoperfusion, and leads to cognitive function impairment,
but also increases cardiac hypertrophy and cardiac dysfunction.
BCAS-induced cognitive deficit is significantly correlated with
cardiac deficit. BCAS leads to cardiac fibrosis, increases leukocyte
and M1 macrophage infiltration, and induces oxidative stress
and inflammatory factor expression of IL-6 and thrombin in the
heart. These data suggest that inflammation and oxidative stress
may contribute to the cardiac dysfunction in BCAS mice.
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FIGURE 3 | Correlation analysis of cognitive and cardiac functions. Correlation analysis of (A) social test S2% discrimination and EF%, (B) odor test discrimination
and EF%, (C) latency and EF%, and (D) CBF and EF%. n = 6/group. *p < 0.05.

BCAS Induces Hypoperfusion and
Cognitive Deficits

BCAS Induces Cardiac Dysfunction
Neurocardiology is an emerging field that elucidates the effect
of cerebral lesion on the heart (36). Dementia patients with a
prior history of heart disease are more likely to have structural
and functional cardiac abnormalities compared with control
normal subjects (36). Heart failure is correlated with dementia
in the elderly, and most clinical patients with heart failure had
dementia, but with dementia onset prior to evident heart failure
(HF), which suggests that dementia may trigger subclinical
onset of heart failure (37). Reduced CBF triggered by cardiac
dysfunction further exacerbates VaD and Alzheimer’s disease
(AD) pathology (38).
In our previous studies, we also observed cardiac dysfunction
and cardiac fibrosis at 28 days after intracerebral hemorrhage
(39), 30 days after ischemic stroke (25, 40), as well as 30 days after
traumatic brain injury (9). In the present study, our data show
that BCAS induces significant cardiac eccentric hypertrophy,
cardiac dysfunction, and cardiac fibrosis compared to sham
mice. Additionally, a significant correlation between cardiac
dysfunction and cognitive dysfunction is shown via the Pearson’s
correlation test. To our knowledge, we are the first to demonstrate
that BCAS-induced VaD leads to cardiac dysfunction in mice
without primary heart disease.

The BCAS model induces chronic cerebral hypoperfusion and
serves as a powerful tool for the investigation of VaD (17). In
our study, we found that BCAS leads to a chronic decrease in
CBF in mice, and these mice develop cognitive impairment.
Thus, this model of BCAS appears as a reasonable model of
VaD and reflects its underlying mechanisms. We found that mice
subjected to BCAS exhibit significant cognitive impairment, as
indicated by the reduced discrimination index in the novel odor
recognition test and the reduced preference for social novelty
in the three-chamber social interaction test. There have been
mixed reports regarding spatial memory impairment evaluated
using the MWM test following BCAS. While some studies report
selective impairment of spatial and working memory after BCAS
without changes in the escape latency or swim speed in MWM
between sham and BCAS mice (11, 31), other studies have
reported significantly increased escape latency in the MWM test
when evaluated at 4, 6, or 8 weeks post-BCAS in young mice
compared to sham control mice (32–35). In our study, BCAS
mice exhibited significantly increased escape latency on all 5
days of testing compared to sham control mice. In addition,
we found that BCAS mice exhibit mild neurological deficits in
the mNSS test and have reduced swim speed in the MWM
test. Therefore, we cannot rule out that motor deficits may
contribute to some of the cognitive differences observed in the
MWM test.

Frontiers in Cardiovascular Medicine | www.frontiersin.org

BCAS Induces Cardiac Fibrosis
Many mechanisms may regulate brain–heart interaction after
brain damage. Inflammatory cell infiltration into the heart and
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FIGURE 4 | Bilateral common carotid artery stenosis (BCAS) significantly increases cardiac fibrosis and oxidative stress compared to sham mice. (A) Picrosirius Red
(PSR) staining and perivascular fibrosis measurement. (B) PSR staining and interstitial fibrosis measurement. (C) 4-Hydroxynonenal (4HNE) staining and quantitative
data. (D) NADPH oxidase 2 (NOX-2) staining and quantitative data. n = 6/group. *p < 0.05.

found that macrophages are increased in the heart of BCAS mice.
BCAS may evoke an increase in cardiac macrophages, which
release fibrogenic cytokines, leading to the deposition of collagen
and subsequent cardiac dysfunction (45).

increased inflammatory factor expression may lead to progressive
cardiac functional deficits after BCAS. Inflammation may be a
mediator of cardiac fibrosis and heart failure (41). Macrophages
play critical roles in the initiation and progression of fibrotic
responses, which are dependent on microenvironmental factors
(42). Macrophages may differentiate into myofibroblasts and
secrete cytokines and growth factors to increase fibrosis (43).
Homeostasis of the cardiac fibroblast results in the disruption
of myocardial excitation–contraction coupling in both systole
and diastole, and disruption of this homeostasis leads to a farreaching impairment of systolic and diastolic function (43).
Activated macrophage infiltration into the heart tissue releases
fibrogenic cytokines that promote fibrosis and remodeling,
eventually leading to cardiac dysfunction (44). In our study, we

Frontiers in Cardiovascular Medicine | www.frontiersin.org

BCAS Increases Cardiac Inflammation
Previous studies found that immune response plays a vital
role in regulating brain–heart interaction after stroke, TBI,
subarachnoid hemorrhage (SAH), and intracerebral hemorrhage
(ICH) (8, 9, 44, 46). Inhibition of the immune response
after stroke, TBI, SAH, and ICH by splenectomy significantly
reduces inflammatory cell infiltration into the heart and
decreases the inflammatory factor and oxidative stress response
in the heart, which may mediate the splenectomy-reduced
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FIGURE 5 | Bilateral common carotid artery stenosis (BCAS) significantly increases inflammatory cell and inflammatory factor gene expression in the heart compared
to sham mice. (A) CD45 immunostaining in the heart tissue and quantitative data. (B) IBA-1 immunostaining and quantitative data. (C) M1 macrophage
immunostaining and quantitative data. (D) IL-6 gene expression. (E) Thrombin gene expression. n = 6/group. *p < 0.05.

cardiac deficit after stroke and TBI (8, 9, 44, 46). The
phenotype and function of macrophages are regulated by
the surrounding microenvironment and can be classified into
two types, with the classically activated or M1 macrophage
regarded as pro-inflammatory and the M2 macrophage as antiinflammatory (47). M1 macrophages induce tissue damage and
initiate inflammatory responses that result in cardiac longterm pathological remodeling (48–50). M1 macrophages produce
many cytokines, including IL-6 (51). IL-6 is a pleiotropic
cytokine, and in the acute phase of ischemia–reperfusion injury
and myocardial infarction in a rat model, it acts as a protective
cytokine to host injury while chronically becomes pathogenic to

Frontiers in Cardiovascular Medicine | www.frontiersin.org

the host, leading to chronic inflammation and cardiac fibrosis
(52). Meta-analysis of human studies has shown that long-term
elevation of IL-6 more than doubles a person’s lifetime risk of
coronary heart disease (53). Increased expression and release of
the inflammatory cytokine IL-6 are observed in HF patients (54).
IL-6 promotes the infiltration and activation of mononuclear
leukocytes (55) and activates the coagulation pathway and
vascular endothelial cells, but inhibits myocardial function (56).
In the present study, we found that M1 macrophage infiltration
into the heart and the expression of IL-6 in the heart were
elevated after BCAS, which may contribute to BCAS-induced
cardiac dysfunction.
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BCAS Induces Oxidative Stress Response
in the Heart

and thrombin expression. However, the mechanisms of
BCAS-induced cardiac deficit have not been definitively
demonstrated and warrant further investigation. There are many
mechanisms involved in brain–heart interaction. The HPA axis
consisting of the hypothalamus, pituitary, and adrenal glands
is an important mediator of brain–heart interaction (77). The
catecholamine released may contribute to cardiac deficits after
VaD. Sympathetic response and elevated systemic catecholamine
levels have been associated with cardiac dysfunction (78).
Sympathetic nerve terminals can release catecholamines directly
into the heart, while the adrenal medulla releases catecholamines
into the blood stream and thereby provoke heart deficit (79).
Takotsubo syndrome (TKS) is an acute cardiomyopathy which
is driven by stressful emotional or physical conditions (80).
Catecholamine-induced myocardial stunning is one of the
suggested mechanisms of TKS (81), which may also be related
to BCAS-induced cardiac deficit. The renin–angiotensin–
aldosterone system (RAAS), also referred to as the angiotensin
(Ang)-converting enzyme/Ang II/Ang type 1 receptor axis, is
altered following cerebrovascular injuries such as stroke and
BCAS-induced hypoperfusion and is known to induce injury
in various organs, affecting cardiac function, renal function,
as well as cognitive function (32, 82, 83). RAAS blockers are
effective in reducing left ventricular hypertrophy, fibrosis,
diastolic dysfunction, and associated cardiac dysfunction (84).
Specifically, in BCAS, direct activation of angiotensin type 2
receptor was found to increase CBF and reduce inflammation,
thereby improving cognitive function in mice (32). RAAS plays
an important role in CBF regulatory mechanisms (85, 86).
Reduced CBF can also increase the secretion of aldosterone from
the adrenals, which in turn can contribute to cardiac remodeling
following BCAS. The role of the RAAS in BCAS-induced cardiac
dysfunction remains to be determined, and further studies
are warranted. The nervous system and the immune system
affect each other via sympatho-adrenergic pathways, suggested
by dopaminergic receptor expression on immune cells (87).
Brain-derived microvesicles (BDMVs) and microRNA mediate
intercellular and inter-organ communication (36). BDMVs
released from injured brain induce systemic coagulopathy, which
may induce cardiac deficits (36, 88). Future studies are warranted
to investigate the mechanisms and test interventions to improve
neurocognitive as well as cardiac function in VaD. In addition, in
this study, we only employ adult male mice; however, we cannot
ignore the effects of age and gender on dementia. With aging and
gender differences, the mechanisms of BCAS-induced cardiac
deficits warrant further investigations.

Growing evidence highlights oxidative stress as an important
mechanism in cardiac deficit (57). Excessive oxidative stress
response impairs the DNA/RNA synthesis and causes cellular
damage, while fibroblasts have been well-documented to utilize
reactive oxygen species (ROS) in differentiation to secrete
collagen, which contributes to cardiac fibrosis (58). 4HNE is a
reactive lipid mediator generated from lipid peroxidation, which
is a biomarker of oxidative stress (59). The degree of lipid
peroxidation is correlated to the severity of cardiovascular disease
(CVD) in patients (60), and 4HNE adducts to mitochondrial
NADP+ -isocitrate dehydrogenase and was shown to enhance
cardiac hypertrophy in a spontaneously hypertensive rat model
(61). NADPH oxidase is an important ROS source in cardiac cells
and modulates several key processes underlying the myocardial
response to injury (62). NOX-2 is the main isoform expressed
in the myocardium (63). ROS, especially from NOX-2, make
a vital contribution to the development of cardiac dysfunction
and remodeling (62, 64). NOX-2 knockout mice exhibit cardiac
protective effects associated with the decrease of oxidative stress
and neutrophil invasion in an ischemia–reperfusion model (65).
NOX-2 also drives macrophages turning into M1 macrophages
(66, 67), which further aggravates the damage. In our study,
we found that BCAS significantly increases 4HNE and NOX2 expression in the heart tissue compared to sham mice.
Collectively, oxidative stress may contribute to cardiac deficits
after BCAS.

BCAS Increases Thrombin Expression in
the Heart
Thrombin, a potent platelet activator, is the central protease
of the coagulation cascade, and it participates in left atrial
remodeling (68), cardiac hypertrophy, and heart failure (69).
Thrombin signals act via protease-activated receptor (PAR)1
and PAR4 on human platelets, which have been implicated in
the generation of ROS (70). In addition, subjects with heart
failure are at higher risk of developing thrombosis, and thrombin
generation is accelerated and amplified in heart failure (71).
In vitro, murine macrophages can be stimulated to polarize into
M1 by thrombin via PAR1 (72). Moreover, thrombin induces IL6 production in fibroblasts (73), which exacerbates tissue injury.
Thrombin overload induces cardiac fibrosis and dysfunction
in mice (74). Thrombin is highly correlated to NOX-2 since
NOX-2 is the key target to activate oxidative stress-mediated
platelet activation and thrombosis (75). Inhibitors of NOX2 block thrombin-induced platelet secretion, aggregation, and
ROS generation (76, 77). In this study, we found that BCAS
increases not only M1 macrophage, IL6, and oxidant stress but
also thrombin expression in the heart. Thus, increased thrombin
may also contribute to BCAS-induced cardiac deficit.

CONCLUSIONS
BCAS in male mice induces cognitive and heart deficits. The
cardiac dysfunction is significantly correlated with cognitive
deficit in BCAS mice. BCAS also increases the inflammatory and
oxidative stress response in the heart in non-primary cardiac
disease mice. Increasing inflammation and oxidant stress in the
heart may contribute to BCAS-induced cardiac deficit.

LIMITATIONS
In this study, we demonstrate that BCAS induces cardiac
deficit and increases cardiac inflammation, oxidative stress,
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